Keyphrases
Atypical Hemolytic Uremic Syndrome (aHUS)
100%
Thrombotic Microangiopathy
93%
Complement System
49%
Complement Activation
48%
Genetic Variants
45%
Complement Factors
40%
Complement Factor H
38%
Management Strategy
30%
Age-related Macular Degeneration
29%
Advanced Age-related Macular Degeneration
28%
Complement Receptors
25%
Kidney
25%
Eculizumab
24%
C3 Glomerulopathy
22%
Kidney Transplantation
20%
Complement Proteins
19%
Variants of Uncertain Significance
17%
Renal Disease
16%
Kidney Transplant
16%
Preeclampsia
15%
Complement Dysregulation
14%
Alternative Pathway
14%
Functional Analysis
14%
Autoimmune Disease
14%
Complement Cascade
13%
Pathophysiology
13%
Etiology
12%
Genetic Testing
12%
Dysregulated
12%
Pregnancy Disorders
12%
Disease-associated
12%
Renal Transplant
12%
Rare Variants
11%
Missense Variants
11%
Complement Regulators
11%
Functional Assay
10%
Complement Pathway
10%
Rare Genetic Variants
10%
Genetic Progression
10%
Early Onset Drusen
10%
Idiopathic Membranous Nephropathy
10%
CD46
10%
COVID-19
10%
Perioperative Evaluation
10%
Cytomegalovirus
10%
Membranous Nephropathy
10%
Postpartum Period
10%
Epithelial Cells
10%
Treatment Preferences
10%
Treatment Quality
10%
Medicine and Dentistry
Atypical Hemolytic Uremic Syndrome
94%
Thrombotic Thrombocytopenic Purpura
85%
Diseases
53%
Complement System
48%
Kidney Graft
42%
Complement Activation
36%
Glomerulopathy
29%
Microangiopathy
24%
Eculizumab
23%
Complement Factor I
20%
Kidney Transplantation
20%
Nephropathy
20%
Age Related Macular Degeneration
17%
Pre-Eclampsia
15%
Diagnosis
14%
Transplantation
14%
Pathophysiology
14%
Membrane Cofactor Protein
13%
Complement Factor H
12%
Autoimmune Disease
12%
Complement Component C3
10%
End Stage Renal Disease
10%
Elevated Transaminases
10%
Low Platelet Count
10%
Quality of Life
10%
Ravulizumab
10%
Puerperium
10%
COVID-19
10%
Complement Regulator
10%
Membranous Glomerulonephritis
10%
Cytomegalovirus
10%
Membranoproliferative Glomerulonephritis
10%
Genetic Screening
10%
Genetic Disorder
10%
Nephrology
10%
Population Health
10%
Chronic Kidney Disease
10%
Autoantibodies
9%
Disease
9%
Systemic Lupus Erythematosus
8%
Genetic Variability
8%
Complement Inhibitor
8%
Antigen Antibody Complex
7%
Thrombosis
7%
End Organ Damage
7%
Immunity
7%
Kidney Disorder
6%
Public Health
6%
Recurrent Disease
6%
Innate Immunity
6%
Immunology and Microbiology
Complement Activation
36%
Factor H
32%
Complement System
30%
Thrombotic Thrombocytopenic Purpura
30%
Complement Receptor 1
23%
Complement Factor I
20%
Fibrinogen
19%
CD46
13%
Wild Type
13%
Autoimmune Disease
12%
Complement Regulator
11%
Eclampsia
10%
Membranous Glomerulonephritis
10%
Kidney Transplantation
10%
Complement Factor
10%
COVID-19
10%
Complement Disorder
10%
Immunity
8%
Inflammation Response
6%
Blood Plasma
6%
C3b
5%
Autoimmunity
5%
Infectious Agent
5%
Complement Factor B
5%
Podocyte
5%
